Over-the-Counter Drugs Recalled After Mixed with Painkillers Prescribed for Chronic Migraine
Novartis has recently recalled medications including Bufferin, Excedrin, Gas-X and NoDoz. The reason: they may have been mistakenly mixed with prescription painkillers — including some used to treat chronic migraine pain.
The pharmaceutical company has also recalled nine prescription opiate painkillers it manufactures for Endo Pharmaceuticals, including some used for migraine treatment.
“Mixing of different products in the same bottle could result in consumers taking the incorrect product and receiving a higher or lower strength than intended or receiving an unintended ingredient,” Novartis warns. “This could potentially result in overdose, interaction with other medications a consumer may be taking, or an allergic reaction if the consumer is allergic to the unintended ingredient.”
All Bufferin products with expiration dates of December 20, 2013 or earlier have been recalled. Brand names include Bufferin Extra Strength Tablets, Bufferin Low Dose Tablets and Bufferin Regular Strength Tablets.
All Gas-X Prevention products with expiration dates of December 20, 2013 or earlier have been recalled.
Sixteen Excedrin products with expiration dates of December 20, 2014 have been recalled, including three designed for migraine treatment — specifically to relieve chronic migraine pain. They include: Excedrin Extra Strength Caplets; Excedrin Extra Strength Express Gel Caplets; Excedrin Extra Strength Gel Caplets; Excedrin Extra Strength Tablets; Excedrin Extra Strength Back & Body Caplets; Excedrin Sinus Headache Caplets; Excedrin Migraine Caplets; Excedrin Migraine Gel Tablets; Excedrin Migraine Tablets; Excedrin Menstrual Complete Express Gel Caplets; Excedrin PM Caplets; Excedrin PM Express Gel Caplets; Excedrin PM Tablets; Excedrin Tension Headache Caplets; Excedrin Tension Headache Express Gel Caplets; and Excedrin Tension Headache Gel Tablets.
Prescription pain medications affected by the packaging mix-up also include several used for migraine treatment. As a result, Endo Pharmaceuticals says it expects to see some shortages of its pain medications — including some prescribed to relieve chronic migraine pain. The medications include: Opana ER Extended-Release Tablets CII; Opana CII; Oxymorphone Hydrochloride Tablets CII; Percocet Tablets CII; Percodan Tablets CII; Endocet Tablets CII; Endodan Tablets CII; Morphine Sulfate Extended-Release Tablets CII; and Zydone CIII.
If you have any of the medications listed above, please discontinue their use. You can also contact Novartis at 888-477-2403 or novartisOTC.com for information on returning the medications for a refund.